Affiliation:
1. Torii Pharmaceutical Co., Ltd.
2. Papermill Medical
Publisher
Pharmaceutical Society of Japan
Subject
Pharmaceutical Science,Pharmacology,General Medicine
Reference13 articles.
1. 1) Hashimoto M, Nigi H, Sakaguchi M, Inouye S, Imaoka K, Miyazawa H, Taniguchi Y, Kurimoto M, Yasueda H, Ogawa T. Sensitivity to two major allergens (Cry j I and Cry j II) in patients with Japanese cedar (Cryptomeria japonica) pollinosis. Clin. Exp. Allergy, 25, 848–852 (1995).
2. 2) Becker S, Schlederer T, Kramer MF, Haack M, Vrtala S, Resch Y, Lupinek C, Valenta R, Gröger M. Real-life study for the diagnosis of house dust mite allergy—the value of recombinant allergen-based IgE serology. Int. Arch. Allergy Immunol., 170, 132–137 (2016).
3. 3) Takai T, Kato T, Sakata Y, Yasueda H, Izuhara K, Okumura K, Ogawa H. Recombinant Der p 1 and Der f 1 exhibit cysteine protease activity but no serine protease activity. Biochem. Biophys. Res. Commun., 328, 944–952 (2005).
4. 4) European Medicines Agency. “Guideline on Allergen Products: Production and Quality Issues.”: ‹https://www.ema.europa.eu/documents/scientific-guideline/guideline-allergen-productsproduction-quality-issues_en.pdf.›, accessed 6 June, 2019.
5. 5) Okubo K, Masuyama K, Imai T, Okamiya K, Stage BS, Seitzberg D, Konno A. Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis. J. Allergy Clin. Immunol., 139, 1840–1848.e10 (2017).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Japanese Cedar Pollen Allergens in Japan;Current Protein & Peptide Science;2022-12